• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [52 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2024 NIHR Health Technology Assessment programme Evaluation of venous thromboembolism risk assessment models for hospital inpatients: the VTEAM evidence synthesis
2024 NIHR Health Technology Assessment programme Thromboprophylaxis during pregnancy and the puerperium: a systematic review and economic evaluation to estimate the value of future research
2024 NIHR Health Technology Assessment programme Early high-dose cryoprecipitate to reduce mortality in adult patients with traumatic haemorrhage: the CRYOSTAT-2 RCT with cost-effectiveness analysis
2023 NIHR Health Technology Assessment programme Techniques to increase lumbar puncture success in newborn babies: the NeoCLEAR RCT
2023 Austrian Institute for Health Technology Assessment (AIHTA) Percutaneous aspiration thrombectomy for pulmonary embolism
2022 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: submission of surgical specimens to the anatomic pathology laboratory: relevance and indications - otolaryngology and oral, maxillofacial and head and neck surgery]
2021 NIHR Health Technology Assessment programme High Or Low Dose Syntocinon for delay in labour (HOLDS)
2021 NIHR Health Technology Assessment programme Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: the PEACOCK study
2020 Norwegian Institute of Public Health (NIPH) [Effectiveness of microwave thermotherapy (TUMT) compared to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia]
2020 NIHR Health Technology Assessment programme Examining the benefit of graduated compression stockings as an adjunct to low dose low molecular weight heparin in the prevention of venous thromboembolism in elective surgical inpatients identified as moderate or high risk for venous thromboembolism a multi-centre randomised controlled trial
2018 Adelaide Health Technology Assessment (AHTA) Extended half-life clotting factor concentrates for the treatment of haemophilia A and B
2018 NIHR Health Technology Assessment programme Amaze: a double-blind, multicentre randomised controlled trial to investigate the clinical effectiveness and cost-effectiveness of adding an ablation device-based maze procedure as an adjunct to routine cardiac surgery for patients with pre-existing atrial fibrillation
2016 NIHR Horizon Scanning Centre (NIHR HSC) Andexanet alfa for acute major bleeding episodes requiring reversal of anticoagulation, including reversal of factor Xa inhibition – first line
2016 NIHR Horizon Scanning Centre (NIHR HSC) Fostamatinib for chronic immune thrombocytopenic purpura
2016 HAYES, Inc. Percutaneous mechanical thrombectomy for deep vein thrombosis
2016 HAYES, Inc. Percutaneous mechanical thrombectomy for pulmonary embolism
2016 NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2016 NIHR Horizon Scanning Centre (NIHR HSC) Ciraparantag for haemorrhage in patients receiving new oral anticoagulants
2016 Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Blood conservation strategies in cardiac surgery: the thromboelastogram and rotational thromboelastometer for monitoring hemostasis in cardiac surgery]
2015 NIHR Horizon Scanning Centre (NIHR HSC) XStat® Hemostatic Device for non-compressible junctional haemorrhage
2014 HAYES, Inc. Portable pneumatic compression versus low-molecular-weight heparin for prevention of deep vein thrombosis after lower-extremity joint arthroplasty
2014 HAYES, Inc. Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2013 Canadian Agency for Drugs and Technologies in Health (CADTH) GreenLight laser for the treatment of benign prostatic hypertrophy: a review of clinical and cost-effectiveness, and safety
2013 HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2012 HAYES, Inc. Fibrinogen-beta (FGB) c.-455G>A polymorphism testing in cardiovascular disease
2012 HAYES, Inc. Factor V (F5) HR2 haplotype testing for hypercoagulability
2012 HAYES, Inc. Factor VII (F7) p.Arg353Gln polymorphism testing
2012 HAYES, Inc. Factor XIIIA1 (F13A1) p.Val34Leu polymorphism testing
2012 HAYES, Inc. Cook celect vena cava filter (Cook Medical Inc.) for prophylaxis and treatment of pulmonary embolism
2012 HAYES, Inc. Pulmonary thromboendarterectomy for treatment of pulmonary hypertension
2012 Canadian Agency for Drugs and Technologies in Health (CADTH) New oral anticoagulants for the prevention of thromboembolic events in patients with atrial fibrillation
2011 HAYES, Inc. Catheter-directed thrombolysis for deep vein thrombosis
2011 HAYES, Inc. Mobile cardiac outpatient telemetry (MCOT) (CardioNet ambulatory ECG monitor; CardioNet Inc.) for home monitoring of cardiac patients
2011 HAYES, Inc. Factor XI Deficiency (Hemophilia C)
2011 HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following hip surgery
2011 HAYES, Inc. Pneumatic compression for prevention of deep vein thrombosis following knee surgery
2011 HAYES, Inc. Hemophilia A (factor VIII deficiency)
2011 HAYES, Inc. NovoSeven coagulation factor VIIa (recombinant) for prevention and control of bleeding in patients without hemophilia
2010 HAYES, Inc. AtriCure devices (AtriCure Inc.) for the thoracoscopic maze procedure
2010 HAYES, Inc. Cardioblate ablation systems (Medtronic Inc.) for atrial fibrillation
2010 HAYES, Inc. Point-of-care thromboelastography and platelet function testing for management of perioperative transfusion therapy in cardiopulmonary bypass patients
2009 HAYES, Inc. Cook implantable doppler blood flow monitor (Cook Medical Inc.) for continuous blood flow assessment
2009 HAYES, Inc. Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) test (PLAC Test) (diaDexus Inc.) for prediction of ischemic stroke
2009 HAYES, Inc. Heparin-bonded polytetrafluoroethylene (PTFE) gore propaten vascular graft (W.L. Gore & Associates Inc.) for treatment of peripheral arterial disease
2009 HAYES, Inc. Pooled human thrombin or recombinant human thrombin versus bovine thrombin for surgical hemostasis
2009 HAYES, Inc. Trellis-8 Peripheral Infusion System (Bacchus Vascular Inc.) for deep vein thrombosis
2008 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Photoselective vaporization for benign prostatic hyperplasia with KTP (potassium-titanyl-phosphate) laser or GreenLight]
2006 Institute for Clinical Effectiveness and Health Policy (IECS) Usefulness of hydroxyethyl starch (HES) as plasma expander
2005 Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Device for treatment of ischemic stroke
2002 Health Technology Advisory Committee (HTAC) Postmenopausal hormone replacement
2002 The Swedish Council on Health Technology Assessment (SBU) Hormone replacement therapy
2001 Medical Advisory Secretariat (MAS) Intracoronary radiation therapy: an evidence-based analysis